IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling - PubMed
IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling
Hai-Yu Xiong et al. Asian Pac J Cancer Prev. 2014.
Free article
Abstract
Background and aim: B7-H1, a co-inhibitory molecule of the B7 family, is found aberrantly expressed in ovarian cancer cells and infiltrating macrophage/dendritic-like cells, and plays a critical role in immune evasion by ovarian cancer. IL-12, an inducer of Th1 cell development, exerts immunomodulatory effects on ovarian cancer. However, whether IL-12 regulates B7-H1 expression in human ovarian cancer associated-macrophages has not been clarified. Therefore, we investigated the effects of IL-12 on the expression of B7-H1 in ovarian cancer-associated macrophages and possible mechanisms.
Methods: PMA induced THP-1-derived macrophages or human monocyte-derived macrophages were treated with recombinant IL-12 (rIL-12) or infected with adenovirus carrying human IL-12 gene (Ad-IL-12-GFP) for 24 h, then cocultured with the SKOV3 ovarian cancer cell line for another 24 h. Macrophages were collected for real-time PCR and Western blot to detect the expression of B7-H1, and activation of the NF-κB signaling pathway. Moreover, supernatants were collected to assay for IL-12, IFN-γ and IL-10 by ELISA. In addition, monocyte-derived macrophages treated with IFN-γ were cocultured with SKOV3 and determined for the expression of B7-H1. Furthermore, the expression of B7-H1 in monocyte-derived macrophages was also evaluated after blocking NF-κB signaling.
Results: The expression of B7-H1 was significantly upregulated in monocyte-derived macrophages treated with rIL-12 or Ad-IL-12-GFP compared with the control groups (p<0.05), accompanied by a remarkable upregulation of IFN-γ (p<0.05), a marked downregulation of IL-10 (p<0.05) and activation of NF-κB signaling. However, the upregulation of B7- H1 was inhibited by blocking the NF-κB signaling pathway (p<0.05). Expression of B7-H1 was also increased (p<0.05) in monocyte-derived macrophages treated with IFN-γ and cocultured with SKOV3. By contrast, the expression of B7-H1 in THP-1-derived macrophages was significantly decreased when treated in the same way as monocyte-derived macrophages (p<0.05), and IL-10 was also significantly decreased but IFN-γ was almost absent.
Conclusions: IL-12 upregulates the expression of B7-H1 in monocyte-derived macrophages, which is possible though inducing the secretion of IFN-γ and further activating the NF-κB signal pathway. However, IL-12 downregulates the expression of B7-H1 in THP-1-derived macrophages, associated with a lack of IFN-γ and inhibition of expression of IL-10.
Similar articles
-
Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, Parsa AT. Bloch O, et al. Clin Cancer Res. 2013 Jun 15;19(12):3165-75. doi: 10.1158/1078-0432.CCR-12-3314. Epub 2013 Apr 23. Clin Cancer Res. 2013. PMID: 23613317 Free PMC article.
-
Seo SK, Seo DI, Park WS, Jung WK, Lee DS, Park SG, Choi JS, Kang MS, Choi YH, Choi I, Yu BC, Choi IW. Seo SK, et al. Life Sci. 2014 Sep 1;112(1-2):82-9. doi: 10.1016/j.lfs.2014.07.021. Epub 2014 Jul 26. Life Sci. 2014. PMID: 25072357
-
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L, Zou W. Curiel TJ, et al. Nat Med. 2003 May;9(5):562-7. doi: 10.1038/nm863. Epub 2003 Apr 21. Nat Med. 2003. PMID: 12704383
-
Jeannin P, Duluc D, Delneste Y. Jeannin P, et al. Immunotherapy. 2011 Apr;3(4 Suppl):23-6. doi: 10.2217/imt.11.30. Immunotherapy. 2011. PMID: 21524164 Review.
-
Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma.
Chung F. Chung F. Mediators Inflamm. 2001 Apr;10(2):51-9. doi: 10.1080/09629350120054518. Mediators Inflamm. 2001. PMID: 11405550 Free PMC article. Review.
Cited by
-
Haines NA, Fowler MG, Zeh BG, Kriete CB, Bai Q, Wakefield MR, Fang Y. Haines NA, et al. Med Oncol. 2024 Jan 29;41(3):67. doi: 10.1007/s12032-023-02281-6. Med Oncol. 2024. PMID: 38286890 Review.
-
Masoumi J, Ghorbaninezhad F, Saeedi H, Safaei S, Khaze Shahgoli V, Ghaffari Jolfayi A, Naseri B, Baghbanzadeh A, Baghbani E, Mokhtarzadeh A, Bakhshivand M, Javan MR, Silvestris N, Baradaran B. Masoumi J, et al. Biomedicines. 2023 Dec 4;11(12):3212. doi: 10.3390/biomedicines11123212. Biomedicines. 2023. PMID: 38137433 Free PMC article.
-
Role of regulation of PD-1 and PD-L1 expression in sepsis.
Zhang T, Yu-Jing L, Ma T. Zhang T, et al. Front Immunol. 2023 Mar 9;14:1029438. doi: 10.3389/fimmu.2023.1029438. eCollection 2023. Front Immunol. 2023. PMID: 36969168 Free PMC article. Review.
-
Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications.
Moon J, Oh YM, Ha SJ. Moon J, et al. BMB Rep. 2021 Aug;54(8):403-412. doi: 10.5483/BMBRep.2021.54.8.054. BMB Rep. 2021. PMID: 34078531 Free PMC article. Review.
-
Regulation and Function of the PD-L1 Checkpoint.
Sun C, Mezzadra R, Schumacher TN. Sun C, et al. Immunity. 2018 Mar 20;48(3):434-452. doi: 10.1016/j.immuni.2018.03.014. Immunity. 2018. PMID: 29562194 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials